Genzyme Says Agreement Reached With Icahn

Biotechnology company Genzyme (GENZ) and billionaire investor Carl Icahn have reached a settlement in their proxy fight, the company said on Wednesday – Reuters

Meet Jasper - The AI Writer

Be the first to comment

Leave a Reply

Your email address will not be published.


This site uses Akismet to reduce spam. Learn how your comment data is processed.